Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ergomed
CRO
Permira takes CRO Ergomed private in £703M buyout deal
The London-based private equity firm Permira shelled out 703.1 million pounds ($886.40 million) to take the CRO Ergomed Clinical Research private.
Joseph Keenan
Sep 7, 2023 5:00am
Ergomed buys up cancer, rare disease CRO MedSource
Dec 14, 2020 8:05am
Swedish developer Modus brings in $15M to fund sickle cell drug
Jul 13, 2018 9:10am
Ergomed pays €5.7M for orphan drug CRO
Sep 29, 2017 9:25am
Chutes & Ladders—BIO elects John Maraganore as new chair
Jun 22, 2017 4:08pm
Chutes & Ladders—Medivation founder Hung takes helm at Axovant
Apr 13, 2017 3:11pm
